17 August 2018
The UK's National Health Service (NHS) has adopted HeartFlow’s artificial intelligence (AI) technology across its network of hospitals to address coronary heart disease.
17 July 2018
US-based molecular diagnostics company Biocept has signed a provider agreement for Alliance Global to market and distribute its Target Selector liquid biopsy tests in the UAE, certain Middle East countries,...
20 February 2018
US-based medical equipment developer Cook Biotech has signed exclusive worldwide global licence agreements for the use of Aziyo Biologics’ Bio Envelope scaffold with neuromodulation devices.
1 February 2018
Swedish medical equipment maker Elekta has entered a collaboration to use IBM Watson Health’s artificial intelligence (AI) based platform, Watson for Oncology, with its digital cancer care solutions.
25 January 2018
Australia-based design company Atomo Diagnostics has partnered with US-based rapid diagnostics developer Access Bio to expand point of care testing for HIV in international markets.
18 January 2018
Pfizer has partnered with molecular information firm Foundation Medicine to develop and commercialise companion diagnostics (CDx) for its oncology portfolio.
10 January 2018
Netherlands-based Qiagen has partnered with Italian in-vitro diagnostics firm DiaSorin to offer its QuantiFERON-TB Gold Plus latent tuberculosis (TB) detection test on LIAISON family platforms.
3 January 2018
UK-based Oncimmune has signed a framework agreement with Genostics, a Chinese molecular diagnostics marketing and distribution firm, for an exclusive licence of its EarlyCDT platform designed for the early detection...